Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02376387 · ClinicalTrials.gov registry record
Evidence Based Evaluation and Acceptance of Donor Hearts for Transplantation
A clinical trial, sponsored by Stanford University.
- Completed
- Registry status
- 4,333
- Enrollment target
NCT02376387: Completed study, sponsored by Stanford University.
NCT02376387 is a clinical trial that has completed, run by Stanford University. The registered enrollment target is 4,333 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02376387 has completed, sponsored by Stanford University.
- COMPLETED
- Registry status
- 4,333 participants
- Enrollment target
Study Summary
The proposed research will provide evidence-based strategies for the evaluation and acceptance of donor hearts for transplantation. This is relevant to public health because judicious expansion of donor hearts used for transplantation will make this life-saving procedure available to a larger number of patients living with end-stage heart disease.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 4,333 participants |
| Start Date | 2015-03 |
| Est. Completion | 2020-05-26 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02376387
The ClinicalTrials.gov registry entry for NCT02376387 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 4,333 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Stanford University, which has 1,744 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 0 interventions.
NCT02376387 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02376387 about?
NCT02376387 is a clinical study titled "Evidence Based Evaluation and Acceptance of Donor Hearts for Transplantation". The proposed research will provide evidence-based strategies for the evaluation and acceptance of donor hearts for transplantation. This is relevant to public health because judicious expansion of donor hearts used for transplantation will make this life-saving procedure available to a larger number...
What is the current status of trial NCT02376387?
This trial is currently completed. The enrollment target is 4,333 participants. The study started on 2015-03. Estimated completion is 2020-05-26.
Who is sponsoring clinical trial NCT02376387?
This trial is sponsored by Stanford University, which has 1,744 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.